Given that mutations in KRAS/LKB1 or TP53 are known upstream drivers of CPS1 overexpression 11, 13, our finding that CPS1 overexpression promotes lung cancer metastasis can be considered as a functional consequence of these driver gene mutations. The gene discussed is KRAS; the disease is lung carcinoma.